サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404656

コンシューマーゲノミクスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年

Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region (North America, Europe), And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
コンシューマーゲノミクスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月13日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンシューマーゲノミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコンシューマーゲノミクス市場規模は、2023年から2030年にかけて24.8%のCAGRを記録し、2030年までに72億米ドルに達すると予測されています。

消費者や医師のDTC（Direct-to-Consumer）キットへの関心の高まりと、それに伴うDNA検査キットの販売増加、そして個別化ゲノミクスの傾向の高まりが、予測期間中の市場拡大を促進すると予想されます。最も一般的な検査は、少数の遺伝子変化を利用して特定の健康特性を予測し、共通の特徴を明らかにし、先祖のヒントを提供します。こうした検査で明らかにできる健康情報の多様化に伴い、遺伝子検査を消費者に直接提供する企業が増えています。

DTCキットに対する消費者や医師の関心の高まり、技術の向上、コンシューマーゲノミクスアプリケーションの増加、政府の支援政策、個別化ゲノミクスの傾向の高まりが、市場拡大の主な要因です。例えば、ScienceDirectの記事によると、DTC（direct-to-consumer）検査は医師の処方箋なしで購入できるため、2022年に普及が進みました。

COVID-19パンデミックは、人々の健康への関心を高め、コンシューマーゲノミクスのような斬新で最先端の方法の探求を促す可能性があります。そのため、COVID-19の診断ツールや効率的な治療法の創出を目的としたDNAベースの研究開発やバイオインフォマティクスへの取り組みが増加しており、予測期間中も市場はかなりの成長率を維持すると予想されます。

コンシューマーゲノミクス市場レポートハイライト

  • 遺伝的関連性セグメントは、最も一般的なタイプの父系検査への関与により、2022年に最大の収益シェアを占めました。
  • 溶解マイクロニードル分野は、1ステップで済み、挿入後にマイクロニードルを取り外す必要がないため、予測期間中に最も速い速度で成長すると予想されます。
  • FamilyTree DNA、AncestryDNA、23andMe, Inc.、MyHeritageなどの企業は、父方と母方の検査をいくつか提供しています。これらの検査は、遺伝的関係や先祖に関する情報を手頃な価格で提供しています。
  • アジア太平洋は、DTC遺伝学に関連する意識の高まりと長期的な研究イニシアチブのための資金調達が可能であることから、予測期間中に最も速いCAGRを経験すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 コンシューマーゲノミクス応用ビジネス分析

  • コンシューマーゲノミクス市場：用途変動分析
  • 遺伝的関連性
    • 遺伝関連市場推計・予測、2018年～2030年
  • 祖先
    • 祖先市場推計・予測、2018年～2030年
  • ライフスタイル、健康、栄養
    • ライフスタイル、ウェルネス、栄養市場推計・予測、2018年～2030年
  • 診断
    • 診断市場推計・予測、2018年～2030年
  • スポーツ栄養と健康
    • スポーツ栄養と健康市場推計・予測、2018年～2030年
  • リプロダクティブヘルス
    • リプロダクティブヘルス市場推計・予測、2018年～2030年
  • 個別化医療・薬理遺伝学的検査
    • 個別化医療・薬理遺伝学的検査市場推計・予測、2018年～2030年
  • その他
    • その他の用途市場推計・予測、2018年～2030年

第5章 地域ビジネス分析

  • コンシューマーゲノミクス市場：地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Ancestry
    • 23andMe, Inc.
    • Gene by Gene, Ltd.
    • Mapmygenome
    • Color Health, Inc.
    • Positive Biosciences, Ltd.
    • Futura Genetics
    • Helix OpCo LLC
    • MyHeritage Ltd.
    • Pathway Genomics
    • Veritas
    • Myriad Genetics, Inc.
    • Illumina, Inc.
    • Amgen, Inc.
    • Xcode Life
    • Diagnomics, Inc.
    • Toolbox Genomics
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of abbreviation
  • Table 3 Global consumer genomics market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 9 Europe consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 10 UK consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Germany consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 12 France consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 13 Italy consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Spain consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Denmark consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Sweden consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Japan consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 21 China consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 22 India consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Australia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Switzerland consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Mexico consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait consumer genomics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Consumer Genomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Consumer Genomics market: Application movement analysis
  • Fig. 15 Global Consumer Genomics market, for genetic relatedness, 2018 - 2030 (USD Million)
  • Fig. 16 Global Consumer Genomics market, for ancestry, 2018 - 2030 (USD Million)
  • Fig. 17 Global Consumer Genomics market, for lifestyle, wellness, & nutrition, 2018 - 2030 (USD Million)
  • Fig. 18 Global Consumer Genomics market, for diagnostics, 2018 - 2030 (USD Million)
  • Fig. 19 Global Consumer Genomics market, for sports nutrition & health, 2018 - 2030 (USD Million)
  • Fig. 20 Global Consumer Genomics market, for reproductive health, 2018 - 2030 (USD Million)
  • Fig. 21 Global Consumer Genomics market, for personalized medicine & pharmacogenetic testing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Consumer Genomics market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Consumer Genomics market: Region movement analysis
  • Fig. 26 North America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 32 France Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 40 China Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 41 India Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 43 Switzerland Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 53 UAE Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 54 Kuwait Consumer Genomics market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-987-6

Consumer Genomics Market Growth & Trends:

The global consumer genomics market size is expected to reach USD 7.20 billion by 2030, registering a CAGR of 24.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rise in consumer and physician interest in direct-to-consumer (DTC) kits, coupled with a subsequent increase in the sales of DNA test kits, and the growing trend of personalized genomics, are expected to drive market expansion over the forecast period. The most common tests utilize a small number of genetic changes to predict certain health characteristics, reveal common traits, and provide ancestry hints. With the expansion of the variety of health information these tests can uncover, an increasing number of companies are offering genetic testing directly to consumers.

The surge in consumer and physician interest in DTC kits, technological improvements, an increase in consumer genomics applications, supportive governmental policies, and the growing trend of personalized genomics are the primary drivers of market expansion. For instance, according to a ScienceDirect article, direct-to-consumer (DTC) tests became more prevalent in 2022 as they could be purchased without a doctor's prescription.

The COVID-19 pandemichas heightened people's concerns about their health, potentially encouraging them to explore novel and cutting-edge methods like consumer genomics. Therefore, the market is expected to maintain its considerable growth rate over the forecast period due to the increasing efforts in DNA-based research and development, as well as bioinformatics, aimed at creating diagnostic tools and efficient therapies for COVID-19.

Consumer Genomics Market Report Highlights:

  • The genetic relatedness segment accounted for the largest revenue share in 2022 due to its involvement in the most common type of paternal testing
  • The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period since it requires only one step, and the microneedle does not need to be removed after insertion
  • Companies such as FamilyTree DNA; AncestryDNA; 23andMe, Inc.; MyHeritage, and others offer several paternal and maternal tests. These tests provide information about genetic relations and ancestry at an affordable cost
  • Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to the increasing awareness related to DTC genetics and the availability of funding for long-term research initiatives

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segment & Scope
    • 1.1.1. Application
    • 1.1.2. Regional Scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Model
  • 1.5. Market Scope & Segment Definition
  • 1.6. Market Model
    • 1.6.1. Market Study, By Company Market Share
    • 1.6.2. Regional Analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
      • 3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
      • 3.2.1.3. Expansion in applications of DTC genetics
      • 3.2.1.3.1. Health testing
      • 3.2.1.3.2. Ancestry
      • 3.2.1.3.3. Genetic relatedness
      • 3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
      • 3.2.1.5. Growing trend of personalized genomics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
      • 3.2.2.2. Misleading results create challenges in adoption of home-based genetic tests
      • 3.2.2.3. Regulatory challenges pertaining to the use of DTC genetic tests
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Consumer Genomics Application Business Analysis

  • 4.1. Consumer Genomics Market: Application Movement Analysis
  • 4.2. Genetic Relatedness
    • 4.2.1. Genetic Relatedness Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Ancestry
    • 4.3.1. Ancestry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lifestyle, Wellness, & Nutrition
    • 4.4.1. Lifestyle, Wellness, & Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Diagnostics
    • 4.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sports Nutrition & Health
    • 4.6.1. Sports Nutrition & Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Reproductive Health
    • 4.7.1. Reproductive Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Personalized medicine & Pharmacogenetic testing
    • 4.8.1. Personalized medicine & Pharmacogenetic testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Other Application Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Consumer Genomics Market: Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Target Disease Prevalence
      • 5.2.2.3. Competitive Scenario
      • 5.2.2.4. Regulatory Framework
      • 5.2.2.5. U.S. Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Target Disease Prevalence
      • 5.2.3.3. Competitive Scenario
      • 5.2.3.4. Regulatory Framework
      • 5.2.3.5. Canada Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Target Disease Prevalence
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Regulatory Framework
      • 5.3.2.5. UK Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Target Disease Prevalence
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Regulatory Framework
      • 5.3.3.5. Germany Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Target Disease Prevalence
      • 5.3.4.3. Competitive Scenario
      • 5.3.4.4. Regulatory Framework
      • 5.3.4.5. France Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Target Disease Prevalence
      • 5.3.5.3. Competitive Scenario
      • 5.3.5.4. Regulatory Framework
      • 5.3.5.5. Italy Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Target Disease Prevalence
      • 5.3.6.3. Competitive Scenario
      • 5.3.6.4. Regulatory Framework
      • 5.3.6.5. Spain Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Target Disease Prevalence
      • 5.3.7.3. Competitive Scenario
      • 5.3.7.4. Regulatory Framework
      • 5.3.7.5. Denmark Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Target Disease Prevalence
      • 5.3.8.3. Competitive Scenario
      • 5.3.8.4. Regulatory Framework
      • 5.3.8.5. Sweden Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Target Disease Prevalence
      • 5.3.9.3. Competitive Scenario
      • 5.3.9.4. Regulatory Framework
      • 5.3.9.5. Norway Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Target Disease Prevalence
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Regulatory Framework
      • 5.4.2.5. Japan Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Target Disease Prevalence
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Regulatory Framework
      • 5.4.3.5. China Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Target Disease Prevalence
      • 5.4.4.3. Competitive Scenario
      • 5.4.4.4. Regulatory Framework
      • 5.4.4.5. India Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Target Disease Prevalence
      • 5.4.5.3. Competitive Scenario
      • 5.4.5.4. Regulatory Framework
      • 5.4.5.5. Australia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.6. Switzerland
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Target Disease Prevalence
      • 5.4.6.3. Competitive Scenario
      • 5.4.6.4. Regulatory Framework
      • 5.4.6.5. Switzerland Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Target Disease Prevalence
      • 5.4.7.3. Competitive Scenario
      • 5.4.7.4. Regulatory Framework
      • 5.4.7.5. Thailand Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.8. South Korea
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Target Disease Prevalence
      • 5.4.8.3. Competitive Scenario
      • 5.4.8.4. Regulatory Framework
      • 5.4.8.5. South Korea Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Target Disease Prevalence
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Regulatory Framework
      • 5.5.2.5. Brazil Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.3. Mexico
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Target Disease Prevalence
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Regulatory Framework
      • 5.5.3.5. Mexico Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.4. Argentina
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Target Disease Prevalence
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Regulatory Framework
      • 5.5.4.5. Argentina Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Target Disease Prevalence
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Regulatory Framework
      • 5.6.2.5. South Africa Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Target Disease Prevalence
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Regulatory Framework
      • 5.6.3.5. Saudi Arabia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Target Disease Prevalence
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. Regulatory Framework
      • 5.6.4.5. UAE Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Target Disease Prevalence
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Regulatory Framework
      • 5.6.5.5. Kuwait Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2022
  • 6.4. Company Profiles/Listing
    • 6.4.1. Ancestry
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. 23andMe, Inc.
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Gene by Gene, Ltd.
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Mapmygenome
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Color Health, Inc.
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Positive Biosciences, Ltd.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Futura Genetics
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Helix OpCo LLC
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. MyHeritage Ltd.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Pathway Genomics
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Veritas
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Myriad Genetics, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. Illumina, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Amgen, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives
    • 6.4.15. Xcode Life
      • 6.4.15.1. Overview
      • 6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic Initiatives
    • 6.4.16. Diagnomics, Inc.
      • 6.4.16.1. Overview
      • 6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic Initiatives
    • 6.4.17. Toolbox Genomics
      • 6.4.17.1. Overview
      • 6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic Initiatives